Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“Are there any new immunotherapy biomarkers?
Sanjay Popat at ITCD 2026 outlines the field. PD-L1 provides guidance but is imperfect. Will STK11/KEAP1 help (TRITON study)?
Other leads – TME, transcriptome, microbiome, neoantigens, circulating biomarkers – incredibly complex.”
More posts featuring Stephen Liu on OncoDaily.
